Age-related Macular Degeneration (AMD) is a common, irreversible blinding condition that leads to the loss of central vision. AMD has a complex aetiology with both genetic as well as environmental risks factors, and share many similarities with Alzheimer's disease. Recent findings have contributed significantly to unravelling its genetic architecture that is yet to be matched by molecular insights. Studies are made more challenging by observations that aged and AMD retinas accumulate the highly pathogenic Alzheimer's-related Amyloid beta (Ab) group of peptides, for which there appears to be no clear genetic basis. Analyses of human donor and animal eyes have identified retinal Ab aggregates in retinal ganglion cells (RGC), the inner nuclear layer, photoreceptors as well as the retinal pigment epithelium. Ab is also a major drusen constituent; found correlated with elevated drusen-load and age, with a propensity to aggregate in retinas of advanced AMD. Despite this evidence, how such a potent driver of neurodegeneration might impair the neuroretina remains incompletely understood, and studies into this important aspect of retinopathy remains limited. In order to address this we exploited R28 rat retinal cells which due to its heterogeneous nature, offers diverse neuroretinal cell-types in which to study the molecular pathology of Ab. R28 cells are also unaffected by problems associated with the commonly used RGC-5 immortalised cell-line, thus providing a well-established model in which to study dynamic Ab effects at single-cell resolution. Our findings show that R28 cells express key neuronal markers calbindin, protein kinase C and the microtubule associated protein-2 (MAP-2) by confocal immunofluorescence which has not been shown before, but also calretinin which has not been reported previously. For the first time, we reveal that retinal neurons rapidly internalised Ab 1-42 , the most cytotoxic and aggregateprone amongst the Ab family. Furthermore, exposure to physiological amounts of Ab 1-42 for 24 h correlated with impairment to neuronal MAP-2, a cytoskeletal protein which regulates microtubule dynamics in axons and dendrites. Disruption to MAP-2 was transient, and had recovered by 48 h, although internalised Ab persisted as discrete puncta for as long as 72 h. To assess whether Ab could realistically localise to living retinas to mediate such effects, we subretinally injected nanomolar levels of oligomeric Ab 1-42 into wildtype mice. Confocal microscopy revealed the presence of focal Ab deposits in RGC, the inner nuclear and the outer plexiform layers 8 days later, recapitulating naturally-occurring patterns of Ab aggregation in aged retinas. Our novel findings describe how retinal neurons internalise Ab to transiently impair MAP-2 in a hitherto unreported manner. MAP-2 dysfunction is reported in AMD retinas, and is thought to be involved in remodelling and plasticity of post-mitotic neurons. Our insights suggest a molecular pathway by which this could occur in the senescent eye leading to complex diseases such as AMD.
The Alzheimer's-related amyloid beta peptide is internalised by R28 neuroretinal cells and disrupts the microtubule associated protein 2 (MAP-2)
George Taylor 
Introduction
Age-related Macular Degeneration (AMD) is a common blinding condition that leads to the irreversible loss of central vision amongst the elderly (Khandhadia et al., 2012; Lotery, 2008) . The disease manifests from midlife onwards to affect over ½ million individuals in the UK (source: Macular Society, UK), or approximately 50 million individuals globally (Gordois et al., 2012) . The current strategy of using anti-vascular growth factor (VEGF) inhibitors to treat the less common neovascular (nv) form is inadequate, as prolonged treatment appears to damage the remaining retinal pigment epithelium (RPE) leading to the geographic atrophy (GA) form of AMD (Grunwald et al., 2015; Lois et al., 2013) . Whilst this treatment has benefited many nvAMD patients by restoring partial sight, its limited effect reveals the restrictions of a therapy based on an incomplete understanding of this complex disease. Moreover, it is almost impossible to maintain initial visual gains seen with anti-VEGF therapy due to the need for indefinite treatment in some patients (Hykin et al., 2016) . The prognosis for GA patients is considerably worse, as there is currently no treatment (Khandhadia et al., 2012) . Recent advances have contributed substantially to revealing the genetic basis of AMD (Fritsche et al., 2013 (Fritsche et al., , 2016 . However, AMD, like other complex chronic degenerative conditions such as Alzheimer's disease (AD), cannot solely be defined by genetics (Sanchez-Mut and Graff, 2015; Sato and Morishita, 2013) . For instance, factors such as an unhealthy lifestyle, poor diet and obesity are all known to play considerable roles in increasing the risks of sight loss (Chiu et al., 2014; Khandhadia et al., 2012; Pikuleva and Curcio, 2014) . To add to this complexity, the Alzheimer's-associated Amyloid beta (Ab) group of misfolding proteins were reported to accumulate in ageing retinas (Ratnayaka et al., 2015) . Such Ab deposits were found in retinal whole-mounts associated with photoreceptor outer segments, the RPE and Bruch's membrane (BrM), as well as in choroidal vessels (Hoh et al., 2010; Koronyo-Hamaoui et al., 2011) . Increased retinal Ab loads were also correlated with advancing age and with high levels of drusen (Anderson et al., 2004) . Of note, Ab was reported to be within drusen, organised into spheres referred to as amyloid vesicles (Anderson et al., 2004; Johnson et al., 2002) . Ultrastructural and confocal immunofluorescence analysis revealed these vesicles to have a concentric ring-like interior permeated with Ab immunoreactivity (Anderson et al., 2004) . Such vesicles also formed a substantial proportion of drusen volume (Anderson et al., 2004; Isas et al., 2010; Luibl et al., 2006 ). It appears that retinal Ab is correlated with advanced forms of AMD (Anderson et al., 2004) , with one study reporting Ab-positive drusen only in patients with AMD (Dutescu et al., 2009 ). Furthermore, well-established AMD risk factors such as cholesterol and high-fat diets are also associated with increased retinal Ab loads (Kauppinen et al., 2016; Khandhadia et al., 2012; Ratnayaka et al., 2015) . This pattern of Ab aggregation suggests that the RPE, the focus of most AMD pathology, may be particularly at risk from Ab. However, Ab also appears to accumulate in specific regions of the neuroretina. For example, Ab immunoreactivity was reported in retinal ganglion cells (RGC) of mice (Guo et al., 2007) and in the inner nuclear layer and RGC of rabbits (Dasari et al., 2011) , whilst curcumin positive Ab plaques were observed in retinal whole-mounts of AD patients (KoronyoHamaoui et al., 2011) . This was not surprising as some retinal neurons express the amyloid precursor protein (APP) (Dutescu et al., 2009; Wang et al., 2011) ; the precursor form from which Ab is cleaved (Benilova et al., 2012) . Ab 1-42 , which is considered to be the most pathogenic and aggregate-prone of the Ab species (Citron et al., 1997) , was shown to increase in RGC with increasing age (Wang et al., 2011) . This observation is consistent with evidence that senescent RPE also produce increasing levels of Ab (Yoshida et al., 2005) . Despite such indications there is very little understanding of how Ab can actually affect retinal neurons. Key questions such as how Ab behaves in the retina and what its long-term effect may be remains unanswered. Here, by utilizing the rat neuroretinal R28 cells (Seigel, 1996) , we assessed how Ab might affect the neuroretina at single-cell resolution. Our findings reveal for the first time that oligomeric Ab 1-42 is rapidly internalised by retinal neurons. Furthermore, exposure to nanomolar (nM) quantities of Ab resulted in the transient downregulation of microtubule associated protein-2 (MAP-2). Our findings also show that retinal neurons retained internalised Ab long after initial exposure. We also show for the first time that subretinally injected Ab 1-42 accumulates in the neuroretina mimicking naturally-occurring patterns of Ab deposition, and indicating that these have the potential to realistically impair retinal MAP-2. Our findings provide new insights into how Ab can target the neuroretina, contributing to chronic degenerative conditions such as AMD.
Materials and methods

Preparation and characterisation of Ab
Human recombinant lyophilized Ab 1-42 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) was purchased from rPeptide (Bogart, GA, USA) for use in experiments. Lyophilized product was solubilized to 1 mg/ mL in HFIP (Sigma, UK), vortexed for 1 min and sonicated for 5 min in a 50 Hz FS100 Frequency Sweep (Decon, UK) bath sonicator to ensure proper reconstitution of samples. Evaporation of HFIP was performed using dry nitrogen and subsequent vacuum desiccation of samples for 30 min to remove residual resuspension solvent. The resultant Ab 1-42 peptidic film was resuspended in DMSO (ACROS Organics, US) to 1 mg/mL, vortexed and allowed to stand for 1 min before being added to a 2 mL Zeba desalting column, equilibrated with Ab buffer (10 mM HEPES, 50 mM NaCl, 1.6 mM KCl, 2 mM MgCl 2 $6H 2 O and 3.5 mM CaCl 2 $2H 2 O pH 7.4) to facilitate buffer exchange. 40 mL of buffer was applied as a stack and the columns spun at 1000 g for 2 min at 4 C to collect eluates containing Ab 1-42 peptide. Samples were subsequently spun at 16,000 g for 30 min in a 4 C-controlled centrifuge to pellet small amounts of unwanted higher molecular weight aggregates, whilst the supernatant containing monomeric Ab was harvested and incubated on ice for 1½ h prior to use in experiments. Peptide concentrations were calculated from the absorbance measured with a Nano drop ND-100 at 280 nm as well as the Ab molar co-extinction efficient of 1490 M À1 cm À1 using Beer Lamberts Law. Typical Ab yields were between 70 and 120 mM, which correspond to Ab concentrations reported by others (Broersen et al., 2011) . A similar technique was used to prepare Alexa Fluor ® 647-tagged Ab 1-42 . In this case, Ab peptides in DMSO were pre-incubated with 20 ml of 1 M sodium bicarbonate and 10 ml of 11.3 nm/ml dye in ddH 2 O for 15 min at room temperature prior to loading into buffer exchange columns. Concentrations of Alexa Fluor ® 647-tagged Ab 1-42 preparations were determined as before; accounting for the contribution of the dye to absorbance readings at 280 nm, as per manufacturer's instructions (Invitrogen, UK). Lo-bind Eppendorf tubes and tips were used during experiments to achieve maximal harvest (Soura et al., 2012) .
Cell culture
R28 cells (Seigel, 1996) (Kerafast Inc., MA, USA) were cultured as described (Seigel, 2014) in a medium consisting of Dulbecco's modified eagle's medium (ThermoFisher, UK), 10% foetal calf serum (FCS) (Sigma, UK), 0.37% NaCO 3 , 0.058% L-glutamine and 100 mg/ml gentamycin (Sigma-Aldrich, UK). Cells were maintained in a humidified incubator at 37 C and 5% CO 2 . Cultures were monitored daily by phase-contrast light microscopy to ensure that cells were maintained at sub-confluent levels. All experiments were carried out between passages 6e22. For confocal immunofluorescence experiments, cells were seeded on 100 mg/ml laminin (Sigma, UK) coated coverslips at sub-confluent levels and experiments performed within 2e5 days. Cultures were incubated with equal volumes of either human oligomeric Ab 1-42 (final concentration of Ab in each well equated to 1000 nM) or vehicle. Coverslips were fixed at 24, 48 and 72 h with 4% paraformaldehyde (PFA) (Sigma, UK) for 15 min at 4 C.
Animals
All aspects of animal studies were carried out in accordance with the U.K Animals (Scientific Procedures) Act, 1986. Furthermore, animal studies complied with ARRIVE guidelines, ethical oversight of the host institution's Local Research Committee and adhered to the statement for use of animals in ophthalmic and vision research by the Association for Research in Vision and Ophthalmology (ARVO). Male and female C57BL/6 mice were sourced from the Biomedical Research Facility (University of Southampton, UK), maintained on a standard 12 h light/dark cycle and allowed access to water and food ad libitum. Animals aged between 4 and 5 months were anaesthetised intraperitoneally with ketamine (6 mg/ml) and dexmedetomidine (0.5 mg/ml). Pupils were dilated with 1% tropicamide and 2.5% phenylephrine drops. Mice were placed under a surgical microscope and subretinally injected using a sharp 34 gauge needle with either 625 nM human oligomeric Ab 1-42 (n ¼ 10 eyes from 10 separate animals) or vehicle (n ¼ 3 eyes from 3 separate animals) in a 2 ml volume. These numbers exclude mice that developed occasional retinal bleeds following subretinal injection. Animals were revived using 0.5 mg/ ml intraperitoneal anti-sedan. Soon after injections, funduscopic images confirmed the presence of subretinal blebs. At 8 days post injection, mice were anesthetised as before and the fundus imaged prior to animals being killed.
Histological analysis
Mice were euthanized on day 8 following exposure to Ab 1-42 or vehicle. Eyes were enucleated within 5 min of euthanasia and were immediately fixed in 4% PFA for 30 min at 4 C, followed by washing in 1Â phosphate buffered saline (PBS) and dissection to remove the anterior portion and lens. Samples were then processed through a series of sucrose gradients to reduce water content via osmotic potential before being embedded in optimal cutting temperature formulation. Serial cryosections of samples at 16 mM intervals were obtained using a Leica CM1850 UV microtome (Leica Microsystems, UK) which were collected on superfrost ® plus glass microscope slides (Thermo Scientific, UK). Sections were then probed with the appropriate set of primary and secondary antibodies.
Immunofluorescence and confocal microscopy
Sub-confluent and confluent R28 cells fixed with 4% PFA on coverslips were permeabilised and blocked with 1% bovine serum albumin (BSA) supplemented with 0.1% Triton X-100 (SigmaAldrich, UK) for 45 min at room temperature. Cultures were probed with the following primary antibodies. Mouse anti-calretinin 6B8.2 (1:200, Millipore, UK), rabbit anti-PKC-a (1:500, Abcam, UK), rabbit anti-b3-tubulin (1:200, Abcam, UK), rabbit anti-calbindin D-28K (1:500, Millipore, UK), rabbit anti-MAP-2 (1:200, Abcam, UK) and mouse monoclonal anti-human Ab 82E1 antibody (1:100; IBL, Japan). Secondary antibodies were goat anti-mouse 488 or 594 (1:200, Invitrogen, UK), goat anti-rabbit 488 or 594 (1:200, Invitrogen, UK) and cytopainter phalloidin iFluor 647 (1:1000, Abcam, UK). Direct visualisation of Ab was achieved via an Alexa Fluor ® 647-tagged motif. Cryosectioned mouse retinal tissues on glass coverslips were washed and coated in blocking serum (10% normal goat serum, 0.3% Triton X-100 in PBS) for 1 h at room temperature. Tissues were probed overnight with rabbit anti-b3-tubulin (1:200, Abcam, UK) and mouse monoclonal anti-human Ab 82E1 antibody (1:100; IBL, Japan) followed by secondary antibodies goat antirabbit 594 (1:200, Invitrogen, UK) and goat anti-mouse 488 (1:200, Invitrogen, UK) for 1 h at room temperature. Cell nuclei were counterstained with 1 mg/ml of 4 0 ,6 0 -diamino-2-phenylindole (DAPI) in all cases. R28 cells on coverslips as well as mouse retinal tissues were embedded in Moweol mounting medium with Citifluor anti-fade between two glass coverslips. Images were acquired using a Leica SP8 laser-scanning confocal microscope (Leica Microsystems, UK). Dynamic information within confocal images remained unaltered in subsequent image manipulations in Leica or Photoshop software.
Transmission electron microscopy
Negative stain transmission electron microscopy (TEM) was performed on Ab 1-42 preparations to visualise their assembly. 5 ml samples were applied to formvar/carbon coated 200 mesh copper grids (Agar Scientific, UK) at 0, 1, 1½, 3, 24 and 48 h post preparation for 5 s and blotted dry. 5 ml of negative stain comprising 3% ammonium molybdate in 0.1 M ammonium acetate buffer (pH 7.0) with 1 grain of sucrose/mL was subsequently applied to grids for 10 s and immediately blotted dry. Grids were allowed to air dry prior to visualising samples on a Hitachi H7000 microscope (Hitachi High Technology, Japan) fitted with a SIS Megaview III plate camera (EMSIS, Germany). We also visualised Ab assembly using immunogold labelling experiments. Here, 5 ml samples were applied to grids for 5 min, rinsed in wash buffer (0.1 M phosphate buffer with 1% BSA) and labelled with a mouse monoclonal 82E1 antibody (1:100; IBL, Japan) for 1 h at room temperature. Unbound antibodies were removed by 3Â rinses in wash buffer prior to incubation with a goat anti-mouse immunogold-conjugated secondary antibody (1:50; Elektron Technology, UK). Following incubation, samples were rinsed an additional 3Â in wash buffer and once in distilled water before being blotted dry. All antibody incubations were performed in 0.1 M PBS with 1% BSA at room temperature. Negative stains of immunogold labelled grids were performed as described earlier.
Statistical analysis
Statistical analysis was performed using GraphPad Prism (GraphPad, USA). Data were subject to the unpaired student's t-test to compare total fluorescence readouts from R28 cells treated with 1000 nM Ab 1-42 (n ¼ 12) vs. cultures treated with vehicle only (n ¼ 10) to assess whether Ab is capable of inducing alterations to MAP-2. Data is shown as mean values ± standard error of the mean (SEM) where a statistical significance of p 0.05 is denoted by a single asterisk.
Results
Establishing timelines for in-vitro extraction of oligomeric Ab
The dynamics of Ab aggregation follows a well-established pattern of self-assembly, where monomers initially associate to form dimer, trimers and oligomers before aggregating into protofibrils and mature fibrils. Soluble oligomeric Ab is known to be the most pathogenic; able to penetrate biomimetic membranes compared to more complex Ab forms (Williams et al., 2010 . Using a well-established protocol of in-vitro Ab preparation (Broersen et al., 2011; Soura et al., 2012) , we identified a suitable time point at which abundant Ab 1-42 oligomers could be readily isolated for our in-vitro and in-vivo experiments. Visualisation of Ab preparations (80e110 mM) at different time points by negative stain TEM revealed discrete structures corresponding to 15e65 nm in diameter at 1 and 1½ h after preparation (Fig. 1A, C) . At 3 h we observed the emergence of protofibrils ( Fig. 1E ), whilst fibrils of growing complexity with progressively heavier negative staining appeared at 24 and 48 h (Fig. 1G, I ). No structures were observed on grids coated with vehicle (Fig. 1K) . In order to confirm that these structures were Ab, we used the 82E1 antibody that only recognises the Ab N-terminus residues 1e16. Immunogold labelling coupled to this antibody showed electron-dense gold particles on structures corresponding to the size of oligomers between 1 and 1½ h (Fig. 1B,  D) , as well as regular patterns of staining along more elaborate protofibrils and mature fibrils at later time points (Fig. 1F, H, J) . However, even by 24 h, not all Ab had assembled into fibrils, indicating a certain degree of heterogeneity amongst immunogoldpositive structures (Fig. 1H ). No immunogold labelling was observed on grids probed with the secondary antibody only (Fig. 1L ). Based on this pattern and rate of Ab aggregation, oligomeric forms were observed to be most prevalent approximately 1½ h after preparation. We therefore harvested oligomeric Ab 1-42 at this critical time point for subsequent in-vitro and in-vivo studies.
R28 cells express important neuronal markers
In order to study dynamic Ab effects on neuroretinal cells at single-cell resolution we utilized the rat R28 cell-line (Seigel, 1996) . The diverse natures of these cultures are comparable to the heterogeneous population of different neuronal cell-types in the mammalian retina (Seigel, 2014; Seigel et al., 2004 ). R28 cells have been shown to express key neuronal markers including calbindin, protein kinase C (PKC) and MAP-2 by microarray, immunocytochemistry and/or immunoblotting analysis (Bodur and Layer, 2011; Seigel et al., 2004 ). As we wished to determine whether Ab could impair neurons by disrupting these markers, we first confirmed their expression by confocal-IF which has not been demonstrated before. Our findings showed the expression of PKC-a (Fig. 2B ), b3-tubulin (Fig. 2C), calbindin (Fig. 2E) , as well as the microtubule associated protein-2 (MAP-2) (Fig. 2F) . We also demonstrated that these neurons expressed calretinin (Fig. 2C, D) , which has not been reported in R28 cells previously.
Ab is rapidly internalised by R28 neuroretinal cells
R28 cultures were treated with either 1000 nM of oligomeric Ab 1-42 or vehicle alone. Neurons were also incubated with Alexa 647-tagged Ab 1-42 . At 24 and 48 h after incubation, confocal-IF microscopy revealed small, discrete signals corresponding to Ab which were mainly intracellular in distribution (Fig. 3AeC, E) . Signals from such internalised Ab particles (untagged as well as tagged Ab) were often quite dim in appearance, and were observed predominantly in the perinuclear region of neurons. By contrast, larger clusters of brighter fluorescent Ab particles, which were evident by 48 h, appeared to be extracellular (Fig. 3D, F) . This trend to aggregate extracellularly continued, and by 72 h appeared as highly visible, large, bright fluorescent clusters (Fig. 3G) . A mixture of Ab particles were therefore observed at 72 h (Fig. 3H) ; smaller internalised Ab particles remained unchanged in size from earlier time points, whilst larger Ab aggregates appeared to have formed extracellularly (Fig. 3G, H) . No signals were evident in vehicle treated controls or cultures treated with the secondary antibody only (Fig. 3I, J) . Cultures treated with vehicle only in tagged Ab experiments showed no signals (Fig. 3K) ; indicating absence of non-specific binding. Importantly, by probing with the anti-82E1 antibody, we confirmed that fluorescent signals in Alexa 647-tagged Ab 1-42 treated cultures were specific for Ab, and that Ab had not disassociated from its fluorescent motif (Fig. 3L) . Ab appears not to have any discernible effects on the expression/distribution of calbindin, PKC or calretinin in R28 neurons (data not shown).
Ab transiently impairs the microtubule associated protein-2 (MAP-2)
The exposure of R28 cultures to physiological amounts of oligomeric Ab 1-42 (1000 nM) resulted in the downregulation of neuronal MAP-2 after 24 h (Fig. 4A, B) . However, no such effects were observed at 48 (Fig. 4C, D) or 72 h (Fig. 4E, F) . Quantification of MAP-2 revealed an approximately 33% reduction in total fluorescence intensity (arbitrary fluorescence units or AFU) compared to vehicle treated cultures (Fig. 4G) . However, MAP-2 fluorescence levels in Ab treated neurons had recovered by 48 h, and appeared to be stable afterwards (Fig. 4H, I ). Although MAP-2 fluorescence was transiently impaired, its intracellular pattern of distribution remained unaffected (Fig. 4AeF) .
Subretinally injected Ab localises to the neuroretina
Although APP/Ab immunoreactivity was previously reported in whole retinal mounts, in RGC, the inner nuclear layer and on photoreceptors (Dasari et al., 2011; Dutescu et al., 2009; Guo et al., 2007; Hoh et al., 2010; Kipfer-Kauer et al., 2010; Koronyo-Hamaoui et al., 2011; Wang et al., 2011) , we wanted to establish whether a predetermined amount of physiological Ab 1-42 was realistically capable of localising to the living retina. To assess if this was possible,~2 ml of oligomeric of Ab 1-42 (625 nM) was subretinally injected into C57BL/6 wildtype mice to recapitulate the elevated Ab burden reported in aged and AMD retinas (Ratnayaka et al., 2015) . Tissues were analysed away from site of the injection to exclude the possibility of erroneously studying retinal sections with any mechanically induced trauma. Importantly, subretinal injections via the sclera ensured that the needle did not pass through the neuroretina which remained intact and undisturbed throughout the procedure. In this way, we ensured that retinal Ab immunoreactivity did not arise due to direct contact of the needle with the retina. Use of the anti-Ab 82E1 antibody excluded the likelihood of APP cross-reactivity, ensuring that signals were only due to the presence of bona fide Ab deposits. Assessment of retinal cross sections by confocal-immunofluorescence 8 days after injections revealed distinct Ab deposits in areas corresponding to RGC, inner nuclear and the outer plexiform layers (Fig. 5A, B) . Optically enhanced confocal sections showed magnified images of these Ab aggregates, which appeared as distinct fluorescence signals distributed in the perinuclear region of neurons (Fig. 5B insert) . No fluorescence signals from Ab were observed in vehicle injected eyes (Fig. 5C ).
Discussion
Several laboratories have demonstrated the presence of Ab aggregates in aged and AMD retinas (Ratnayaka et al., 2015) . These studies using histological and confocal-immunofluorescence approaches in wildtype rodent, rabbit, as well as human donor eyes showed Ab deposits predominantly in the outer retina, focused around the RPE; specifically within drusen, in the RPE-BrM interface and on photoreceptor outer segments (Anderson et al., 2004; Hoh et al., 2010; Isas et al., 2010; Johnson et al., 2002; Luibl et al., 2006) . One such study showed that nM amounts of oligomeric Ab induced a pro-inflammatory environment by elevating interleukin-8 and matrix metalloproteinase-9 in RPE, whilst driving cellular senescence and damaging the RPE barrier function (Cao et al., 2013) . Similar findings by other groups revealed that Ab also activated the complement system to bring about a state of chronic inflammation in subretinal tissues (Catchpole et al., 2013; Koyama et al., 2008; Wang et al., 2008 Wang et al., , 2012b Yoshida et al., 2005) . However, retinal neurons are also immunopositive for APP/Ab (Dasari et al., 2011; Dutescu et al., 2009; Guo et al., 2007; Hoh et al., 2010; Kipfer-Kauer et al., 2010; Koronyo-Hamaoui et al., 2011; Wang et al., 2011) , suggesting that Ab activity is not exclusive to the RPE. Therefore, to fully understand how Ab could impair the senescent eye, it was important to study whether the neuroretina is also affected by this neurotoxic group of peptides. We therefore set Recent insights into Ab-mediated pathogenicity showed that oligomeric rather than fibrillar Ab to be the most toxic and closely associated with AD neuropathology (Benilova et al., 2012; McLean et al., 1999) . Although both oligomeric and fibrillar Ab have been reported surrounding the RPE (Isas et al., 2010; Luibl et al., 2006; Ratnayaka et al., 2015) , there is a scarcity of such details with respect to Ab deposits in the neuroretina itself. Here, we sought to determine the effects of oligomeric Ab in the retina due to its strong associations with neuronal dysfunction. With regards to Ab species, both Ab 1-40 and Ab 1-42 are likely to be present in the retina, as their soluble forms were reported in pico-nano molar range concentrations in bovine vitreous (Prakasam et al., 2010) . Our studies focused on oligomeric Ab 1-42 ; as this highly neurotoxic and aggregateprone Ab species has been the focus of considerable work in neurodegeneration (Benilova et al., 2012; Soura et al., 2012) . As neurons in the central nervous system are known to secrete small soluble Ab forms (Benilova et al., 2012; McLean et al., 1999) , we reasoned that this was also likely to be the case in the retina, particularly as some retinal neurons are immunopositive for APP/Ab (Dasari et al., 2011; Dutescu et al., 2009; Guo et al., 2007; Koronyo-Hamaoui et al., 2011; Wang et al., 2011) . The use of antibodies that cannot distinguish between APP vs. Ab in past studies (Dasari et al., 2011; Wang et al., 2011) have resulted in some confusion. Nonetheless, APP/Ab immunoreactivity is likely to correspond to discrete Ab deposits, at least in some instances (Guo et al., 2007; Kipfer-Kauer et al., 2010; Koronyo-Hamaoui et al., 2011) . Given the long term nature of such Ab deposits, these are probably fibrillar in nature (Benilova et al., 2012; Williams et al., 2010) . A dynamic equilibrium is thought to exist between fibrillar Ab deposits and toxic Ab oligomers, creating a local spillover of neurotoxic Ab species in surrounding tissues (Benilova et al., 2012) . Hence, retinal Ab deposits may act as a persistent reservoir for toxic Ab forms such as oligomers. Neurons of the retina are therefore likely to be exposed to soluble oligomeric Ab from several sources. Consequently, our experiments sought to recapitulate conditions where neuroretinal cells were exposed to at least one Ab conformation (oligomeric), species (Ab 1-42 ) and physiological amounts (nM concentrations) that the living retina might realistically be exposed to over decades. As it was important to use oligomeric Ab, we first investigated the aggregation dynamics of Ab 1-42 in our preparations to determine when they were most prevalent. Our negative stain TEM and immunogold labelling experiments consistently showed discrete particles ranging between 15 nm and 65 nm in diameter, which corresponded to the reported size of Ab oligomers (Williams et al., 2010) . These were abundantly visible at~1½ h after preparation; the time point at which they were harvested for use in our experiments. There is considerable debate as to how Ab might mediate its pathogenicity. Several models have been proposed include carpeting, pore-forming and detergent-like mechanisms by which membrane-damage may occur ). In the current study, we observed that retinal neurons internalised Ab as early as 24 h after exposure. Our previous work in SH-SY5Y neurons and in cultured hippocampal cells showed that Ab was internalised via clathrin-positive membrane invaginations (Soura et al., 2012) . These findings were consistent with observations that clathrinmediated mechanisms may at least be partly involved in Ab internalisation (Song et al., 2011; Wu and Yao, 2009 ). Although we did not test internalisation mechanisms per se, similar processes may also be involved in the retina. We assessed the capacity of Ab to enter R28 neurons by two approaches; by using a secondary antibody to probe for untagged Ab, and by directly tagging Ab with a fluorescent Alexa Fluor moiety. We reasoned that the former approach was least likely to interfere with conformational arrangements and thus preserve the 'endogenous' nature of Ab oligomers. Nonetheless, both methods consistently demonstrated that Ab had entered neurons by 24 h. Although we exposed neurons to oligomeric Ab, once in culture, further experimental manipulation became more difficult. For instance, we cannot regulate the rate of aggregation or the manner in which Ab may subsequently behave. However, Ab assembly is known to be influenced by local conditions such as temperature, the presence of reactive oxygen species, metals, cholesterol as well as nearby Ab deposits (Al-Hilaly et al., 2013; Benilova et al., 2012; Wang et al., 2012a; Williams et al., 2010) . Such parameters are likely to impact on how and where Ab may aggregate in susceptible retinas. We reasoned that Ab particles that successfully entered neurons were likely to be oligomeric in nature as these are known to be highly penetrative (Benilova et al., 2012; . We observed that the relative size of such internalised Ab particles did not alter and remained consistently stable for at least 72 h. In contrast, a proportion of oligomers seemed to have undergone further assembly; appearing as large fluorescent clusters on cell surfaces. These appear to be extracellular; their larger size and apparent inability to enter neurons suggesting that they were perhaps no longer oligomeric. An observation consistent with a report that fibrillar Ab, compared to oligomers, are less liable to enter through membranes (Williams et al., 2010) . Insightful as our findings are, these experiments were carried out in R28 neurons, and we cannot rule out the possibility that primary neuroretinal cells may internalise Ab at different rates. For example, RPE cell-lines and primary RPE cells phagocytose photoreceptor outer segments at different rates (Mazzoni et al., 2014) . Genetically and phenotypically however, R28 cells are highly suitable for these studies, as they display the diversity of different neuronal types in the living retina (Seigel, 2014; Seigel et al., 2004) . Moreover, these cells do not suffer from problems associated with the widely utilized RGC-5 immortalised cell-line; which was once thought to be a rat retinal ganglion cellline (Krishnamoorthy et al., 2001 ) but was recently demonstrated to be a transformed mouse photoreceptor cell-line instead (Krishnamoorthy et al., 2013) . This has led to those using the RGC-5 cell-line urging fellow researchers to first establish the expression of specific retinal markers before considering their use as 'retinal ganglion-like cells' (Sippl and Tamm, 2014; Van Bergen et al., 2009) . Prior to studying possible Ab effects, we also demonstrated for the first time that R28 neurons express calbindin, PKC-a and MAP-2 by high-resolution confocal microscopy. This confirms their presence reported earlier by microarray, immunocytochemistry and/or immunoblotting approaches (Bodur and Layer, 2011; Seigel et al., 2004) . We also showed for the first time that R28 cells express calretinin; a neuronal Ca 2þ -binding protein involved in calcium signalling.
We found that exposure to nM quantities of oligomeric Ab for 24 h had downregulated MAP-2. The extent of this impairment was considerable, corresponding to~33% loss of MAP-2 fluorescence intensity compared to controls. Previous studies of MAP-2 have also used immunofluorescence and immunohistochemistry quantification to gain insights into its behaviour (Kharlamov et al., 2009; Lingwood et al., 2008; Yan et al., 2010) . Without further studies, we are unable to comment on potential mechanisms that underlie transient MAP-2 impairment. However, insights may be found in studying interactions between the AD-associated tau protein, which share homology with MAP-2 (Dehmelt and Halpain, 2005) , and Ab (Do et al., 2014) . MAP-2 is typically expressed in axons and dendrites of neurons. MAP-2 expression has been reported in anuran (Gabriel et al., 1992) , avian and mammalian retinas (Okabe et al., 1989; ; specifically in RGC (Okabe et al., 1989; Smith et al., 2008) , amacrine cells (Gabriel et al., 1992) as well as in cell bodies and inner segments of photoreceptors . MAP-2 binds tubulin via multiple domains at its C-terminus to promote the polymerisation of microtubules, whilst its N-terminus contains a projection domain exerting a long-range repulsive action (Dehmelt and Halpain, 2005) . MAP-2 upregulation is strongly correlated with stabilising dendrites and is required for activity-dependent stabilisation of new dendritic arbours (Vaillant et al., 2002) . Furthermore, MAP-2 is critical to maintaining the spacing between microtubules (Harada et al., 2002; Teng et al., 2001) , and protects dendritic microtubules from microtubule-severing enzymes such as katanin that could otherwise destabilise dendrites (Sudo and Baas, 2010) . Although MAP-2 activities have not been extensively investigated in the eye, it is likely to carryout similar functions in the retina. MAP-2 is expressed by R28 neurons (Seigel et al., 2004) , while MAP-2 immunoreactivity is reported to be a reliable and quantifiable marker of early neuronal injury (Lingwood et al., 2008) . Our studies showed that 48 h after Ab exposure, there were no longer any differences between treated and control cultures, suggesting that either Ab was unable to disrupt MAP-2 beyond 24 h and/or that adaptive responses to chronic Ab exposure had restored MAP-2 by then. Such apparently transient Ab effects have also been reported by others (Benilova et al., 2012; Dal Pra et al., 2011) . We also observed that Ab-mediated damage was specific to MAP-2, as there were no discernible effects on retinal calbindin, PKC or calretinin.
Use of in-vitro neuroretinal cultures was critical in obtaining single-cell readouts via high-resolution imaging, which would not have been possible in whole in-situ retinas. Direct experiments of this nature in living retinas would also pose considerable problems to studying dynamic aspects of Ab-mediated pathogenicity. Similar issues confront studies into the AD brain, which has resulted in researchers exploiting numerous cell culture models to address fundamental questions. Indeed, we have previously used cultured neurons to demonstrate that dynamic activities of actin underpin extrasynaptic vesicle recycling in the hippocampus (Ratnayaka et al., 2011 ). An important question that still remained to be clarified was; how likely is Ab to impair MAP-2 in the living retina? Previous studies have indicated neurons in the RGC and the inner retina to be immunopositive for Ab (Dutescu et al., 2009; Guo et al., 2007; Kipfer-Kauer et al., 2010) . However, several of these studies utilized antibodies that do not necessarily distinguish between Ab and APP (Dasari et al., 2011; Wang et al., 2011) . In order to assess if such an outcome might be realistic, we subretinally injected oligomeric Ab 1-42 in nM amounts into wildtype C57BL/6 mice; in proximity to where Ab synthesis/deposition is reported to be most prevalent (Anderson et al., 2004; Hoh et al., 2010; Isas et al., 2010; Johnson et al., 2002; Luibl et al., 2006) . When retinas were analysed after 8 days, distinct areas corresponding to focal Ab deposits were observed in the RGC, the inner nuclear and outer plexiform layers in addition to subretinal Ab aggregates. The accumulation of Ab within these retinal layers supported the realistic possibility that MAP-2 activity in axons/dendrites of RGC, bipolar, horizontal and photoreceptors may be targeted by Ab. Use of the anti-Ab 82E1 antibody precluded the possibility of APP cross-reactivity, and demonstrated for the first time that Ab was indeed capable of accumulating in living retinas after chronic exposure; thus recapitulating the pattern of Ab deposition reported in native tissues (Dasari et al., 2011; Dutescu et al., 2009; Guo et al., 2007; Hoh et al., 2010; Kipfer-Kauer et al., 2010; Koronyo-Hamaoui et al., 2011; Wang et al., 2011) . Immuno-surveillance by migratory retinal microglia/microphages have been shown to engulf retinal Ab (Hoh et al., 2010) . Although we did not specifically probe for microglia/ macrophages, the pattern of Ab deposition observed excludes the likelihood that they originated from such migratory scavengers which display a distinct starburst morphology (Hoh et al., 2010; Walsh et al., 2005) . Once introduced subretinally into the living retina, we were also unable to distinguish between oligomeric and fibrillar Ab. However, based on our understanding of how Ab behaves in-vitro, under culture conditions and in other studies (Benilova et al., 2012; Williams et al., 2010) , we speculate that a majority of oligomeric Ab 1-42 had formed in-situ fibrillar retinal deposits. This does not preclude the possibility that some oligomers persisted, as we detected the presence of smaller Ab forms in-vitro and in cultures at later time points, consistent with the possibility that toxic oligomers could exist in equilibrium around fibrillar Ab deposits (Benilova et al., 2012) .
Although MAP-2 dysregulation had been implicated in AMD retinas, until now there were no insights into how this could occur. For instance, an association of MAP-2 variants were reported in patients with advanced AMD (Zhang et al., 2008) , whilst analysis of donor GA AMD retinas revealed MAP-2 labelling in the inner segments of abnormal photoreceptors with neurite sprouts, tortuous axons and abnormally located nuclei . However, not all such abnormal neurons were MAP-2 positive. Hence, the authors speculate that MAP-2 expression may be transient and expressed only during neuro-morphogenesis ) that occurs in post-mitotic neurons (Grandel et al., 2006; Reye et al., 2002; Rich et al., 1997) . If Ab is capable of transiently impairing MAP-2, it may hinder the processes of neuronal plasticity reported in AMD retinas . Our future studies will assess if transient MAP-2 impairment can be visualised or 'captured' in-vivo by culling mice at earlier time points. In this way we will be able to draw direct comparisons between in-vitro and in-vivo Ab effects. Similar Ab effects on other cytoskeletal components including actin may affect extrasynaptic signalling that also underpins neuronal plasticity (Ratnayaka et al., 2011) . These subtle mechanisms may not only contribute to chronic retinal damage, but may also help explain different AMD phenotypes, for instance when primary photoreceptor pathology is observed without apparent damage to the underlying RPE (Bird et al., 2014) . Such a possibility is supported by studies showing that Ab is capable of inducing a variety of retinal pathophysiologies, for instance when intravitreal Ab injections in rodents resulted in retinal inflammation (Howlett et al., 2011; Walsh et al., 2005 ) -a well-documented feature in AMD retinas (Kauppinen et al., 2016; Khandhadia et al., 2012) . The therapeutic benefits of reducing retinal Ab was highlighted in an elegant study where visual abnormalities in a human ApoE4 knock-in mouse that was aged and fed a high fat diet were abolished by anti-Ab immunotherapy (Ding et al., 2011) . Furthermore, reducing Ab formation, clearance of Ab deposition as well as inhibiting Ab aggregation in a mouse study of experimentally-induced glaucoma not only revealed the role of Ab in other retinal disorders, but also highlighted the therapeutic benefits of inhibiting its retinal activities (Guo et al., 2007) . Our findings show how Ab is rapidly internalised to accumulate within retinal neurons, whilst a proportion of extracellular Ab appear to assemble, perhaps forming focal Ab deposits observed in aged/ AMD retinas. Specific Ab-mediated damage to MAP-2 in cultured neurons as well as Ab deposition in living retinas suggests that it has the capacity to impair neuronal modelling and plasticity. Related questions such whether other Ab species may be involved, what effects longer Ab exposures may produce, and what other cytoskeletal elements may be targeted remains the subject of further studies in our laboratory.
